Invesco Bulletshares 2028 Treasury Bond ETF

BSTS · ETF

$24.85−$0.012 (−0.05%)TodayMarket closed ·
Prev close $24.87

About BSTS

BSTS was created on 2026-06-10 by Invesco. The fund's investment portfolio concentrates primarily on investment grade fixed income. The ETF currently has 9.43m in AUM and 50 holdings. BSTS tracks an index of US Treasury bonds maturing in 2028. The fund seeks to provide exposure to a defined-maturity Treasury bond portfolio that transitions to cash and cash equivalents as its holdings mature.

Issuer
Invesco
Tracks
ICE BulletShares US Treasury Bond 2028 Index - USD - Benchmark TR Gross
Expense ratio
0.07%
Assets under management
$9.41M
Inception
Jun 10, 2026
Asset class
Fixed Income

BSTS key statistics

Price-earnings ratio
0.00
Average volume
6.79K
Volume
14.85K
Open price
$24.86
High today
$24.88
Low today
$24.84
52 Week high
$25.15
52 Week low
$24.73

Invesco Bulletshares 2028 Treasury Bond ETF (BSTS) at a glance

As of Oct 23, 2026, Invesco Bulletshares 2028 Treasury Bond ETF (BSTS) shares are priced at $24.85, giving the company a price-to-earnings ratio of 0.00.

Today the fund has traded between $24.84 and $24.88. The current price is 0.1% above the day's low and 0.1% below its high.

Volume so far is 14.85K shares, above the average of 6.79K shares a day.

Over the past year Invesco Bulletshares 2028 Treasury Bond ETF has ranged from $24.73 to $25.15, and now sits 30% of the way up that range.

BSTS news

  • Chandrima Sanyal

    Invesco Adds New Treasury Exposure To Its $27.6 Billion BulletShares Franchise

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.